The lack of MICA and MICB expression of MCC cells is likely to contribute to this immunological state as re-induction of these NKG2D ligands by HDAC inhibition restores the susceptibility of MCC cells to cytotoxic lymphocytes. The gene discussed is MICB; the disease is Merkel cell skin cancer.